Company news
Bliss GVS Pharma Limited news in 2025
Bliss GVS Pharma Limited's news releases, calls and decks from 2025, newest first.
Bliss GVS Pharma board approves appointment of S.N. Kamath as Managing Director
December 23, 2025
Bliss GVS Pharma Incorporates Theralife Pharma In Kenya
November 25, 2025
Bliss GVS Pharma Sept-Quarter Consol Net Profit 272.5 Million Rupees
November 6, 2025
Bliss Gvs Pharma Receives Tax Demand Of 166.9 Million Rupees From Tax Department
October 7, 2025
Bliss GVS Pharma Ltd - Appoints Narsimha Shibroor Kamath As CEO
September 30, 2025
BLISSGVS: Strong Q1 FY26 growth in revenue and profit, with key subsidiary divestment completed
July 30, 2025
Bliss GVS Pharma June-Quarter Consol Net Profit 430.4 Million Rupees
July 29, 2025
Bliss GVS Pharma Gets Show Cause From Tax Department Over Recovery Of Refund Of 66.4 Million Rupees
July 2, 2025
BLISSGVS: Revenue up, net profit down; subsidiary sale and dividend declared, restructuring ahead
May 2, 2025
BLISSGVS: Quarterly revenue and profit grew modestly, with stable performance in core pharma operations
January 28, 2025